The mechanisms by which IL-12 may enhance T-cell–mediated immunotherapy are manifold and not fully understood.11 12 IL-12 amplifies the antitumor function of cytotoxic T cells including CD8 T cells, natural killer cells, and natural killer T cells, and it is not clear that recognition of tumor antigens is always required for its effects. This evidence concerns the gene CD8A and neoplasm.